Literature DB >> 15236450

Permeability of tritiated water through human cervical and vaginal tissue.

Alexandra B Sassi1, Kristy D McCullough, Marilyn R Cost, Sharon L Hillier, Lisa Cencia Rohan.   

Abstract

The increased incidence of human immunodeficiency virus infection in women has identified an urgent need to develop a female-controlled method to prevent acquisition of human immunodeficiency virus and other sexually transmitted diseases. Women would apply the product intravaginally before intercourse. Development of such a product requires a better understanding of the permeability characteristics of the tissues with which such products would come into contact. However, limited studies have been performed in this area. In the present study, water permeability of fresh human cervical and vaginal tissue was evaluated. The average apparent permeability coefficient was found to be 8 x 10(-5) cm/s for fresh human cervical tissue and 7 x 10(-5) cm/s for fresh human vaginal tissue. Considering the lack of regularity in obtaining cervical and vaginal tissue from surgical specimens, additional tests were performed to evaluate the effect of freezing on tritiated water permeability. No statistically significant differences were observed in the permeability values obtained when comparing fresh versus frozen tissues. Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93:2009-2016, 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236450     DOI: 10.1002/jps.20107

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory.

Authors:  Anthony R Geonnotti; David F Katz
Journal:  Biophys J       Date:  2006-06-30       Impact factor: 4.033

Review 2.  Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.

Authors:  Anthony S Ham; Robert W Buckheit
Journal:  Ther Deliv       Date:  2015-02

3.  The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.

Authors:  Anthony S Ham; Sean T Nugent; Jennifer J Peters; David F Katz; Cory M Shelter; Charlene S Dezzutti; Ashlee D Boczar; Karen W Buckheit; Robert W Buckheit
Journal:  Antiviral Res       Date:  2015-06-17       Impact factor: 5.970

4.  The biological seal of the implant-soft tissue interface evaluated in a tissue-engineered oral mucosal model.

Authors:  Wen L Chai; Ian M Brook; Anders Palmquist; Richard van Noort; Keyvan Moharamzadeh
Journal:  J R Soc Interface       Date:  2012-08-22       Impact factor: 4.118

5.  The Effect of Commonly Used Excipients on the Epithelial Integrity of Human Cervicovaginal Tissue.

Authors:  Minlu Hu; Tian Zhou; Charlene S Dezzutti; Lisa C Rohan
Journal:  AIDS Res Hum Retroviruses       Date:  2016 Oct/Nov       Impact factor: 2.205

6.  The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics.

Authors:  David P Wilson; Paul M Coplan; Mark A Wainberg; Sally M Blower
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

7.  Preformulation studies of EFdA, a novel nucleoside reverse transcriptase inhibitor for HIV prevention.

Authors:  Wei Zhang; Michael A Parniak; Hiroaki Mitsuya; Stefan G Sarafianos; Phillip W Graebing; Lisa C Rohan
Journal:  Drug Dev Ind Pharm       Date:  2013-07-10       Impact factor: 3.225

8.  A novel vaginal drug delivery system: anti-HIV bioadhesive film containing abacavir.

Authors:  Kajal Ghosal; Alok Ranjan; Benoy Brata Bhowmik
Journal:  J Mater Sci Mater Med       Date:  2014-04-04       Impact factor: 3.896

9.  In vitro transport characteristics of EFdA, a novel nucleoside reverse transcriptase inhibitor using Caco-2 and MDCKII cell monolayers.

Authors:  Wei Zhang; Michael A Parniak; Stefan G Sarafianos; Philip E Empey; Lisa C Rohan
Journal:  Eur J Pharmacol       Date:  2014-03-29       Impact factor: 4.432

10.  Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles.

Authors:  Anthony S Ham; Marilyn R Cost; Alexandra B Sassi; Charlene S Dezzutti; Lisa Cencia Rohan
Journal:  Pharm Res       Date:  2008-11-11       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.